| 5955 |
Centers for Disease Control and Prevention |
Html |
en |
Pindone - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6881 |
Centers for Disease Control and Prevention |
Html |
en |
Highly Pathogenic Avian Influenza A (H5N1) Viruses in Asia |
Highly Pathogenic Avian Influenza A (H5N1) Viruses in Asia - CDC |
| avian influenza | 0.485574 |
| vaccine virus candidate | 0.420814 |
| CDC | 0.274636 |
| pandemic preparedness activities | 0.304128 |
| United Nations | 0.261919 |
| avian influenza viruses | 0.429945 |
| vaccine production | 0.260714 |
| greater threat | 0.256414 |
| U.S. government | 0.257391 |
| infected birds | 0.256283 |
| human health | 0.416089 |
| wild birds | 0.367221 |
| Middle East | 0.267378 |
| human exposures | 0.258019 |
| Disease Control | 0.262207 |
| H5N1 influenza viruses | 0.577473 |
| World Organization | 0.258221 |
| pathogenic avian influenza | 0.36843 |
| additional risk | 0.254383 |
| media coverage | 0.319347 |
| infected poultry | 0.304609 |
| subsequent media stories | 0.307191 |
| Sporadic human cases | 0.316365 |
| public health | 0.262631 |
|
| virus infections | 0.293813 |
| infect humans | 0.284018 |
| Recent media coverage | 0.319012 |
| press release | 0.269017 |
| exact match | 0.255958 |
| H5N1 viruses | 0.906266 |
| World Health Organization | 0.310161 |
| routine surveillance | 0.257422 |
| influenza vaccines | 0.280883 |
| FAO report | 0.320809 |
| H5N1 virus | 0.604314 |
| high mortality | 0.26715 |
| H5N1 poultry vaccines | 0.477504 |
| Agriculture Organization | 0.320184 |
| Human-Animal Interface | 0.257253 |
| different groups | 0.258849 |
| H5N1 poultry vaccine | 0.479603 |
| Animal Health | 0.261008 |
| different clades | 0.265866 |
| H5N1 virus infection | 0.500501 |
| severe illness | 0.260034 |
| humans | 0.310552 |
| poultry industry | 0.294264 |
|
CLICK HERE |
| 7163 |
Centers for Disease Control and Prevention |
Html |
en |
Tobacco Use Among Middle and High School Students --- United States, 2000--2009 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Human Services | 0.355667 |
| small brown cigarettes | 0.354378 |
| tobacco tax increases | 0.385894 |
| tobacco control programs | 0.461921 |
| smoking cigarettes | 0.393194 |
| Youth Tobacco Survey | 0.457658 |
| tobacco | 0.71194 |
| current smoking | 0.364864 |
| overall tobacco | 0.377879 |
| Tobacco Control Act§§ | 0.387488 |
| comprehensive tobacco control | 0.556176 |
| tobacco brand | 0.370583 |
| cigarette smoking experimentation | 0.71545 |
| study period | 0.423453 |
| tobacco industry | 0.370738 |
| high school smoking | 0.388671 |
| current cigarette | 0.585568 |
| tobacco products | 0.412717 |
| school response rate | 0.358339 |
| cigarette smoking* | 0.38427 |
| cigarettes | 0.42525 |
| Tobacco Free Kids | 0.385745 |
| Family Smoking Prevention | 0.361778 |
| current tobacco | 0.560405 |
|
| youth cigarette | 0.39948 |
| adult smoking rates | 0.362755 |
| susceptibility | 0.408112 |
| United States | 0.449334 |
| best friends | 0.354729 |
| high school dropout | 0.358967 |
| youths | 0.351633 |
| cigarette smoking | 0.800541 |
| current smoker | 0.36399 |
| overall declines | 0.406999 |
| tobacco pipes | 0.366375 |
| tobacco product | 0.413446 |
| overall decline | 0.36265 |
| middle school students | 0.667282 |
| tobacco related indicators | 0.385867 |
| national YRBS | 0.352459 |
| high school students | 0.982298 |
| tobacco control policies | 0.463523 |
| adult tobacco | 0.370299 |
| National Youth Tobacco | 0.457591 |
| youth smoking | 0.351138 |
| smokeless tobacco | 0.534416 |
| cigarette packages | 0.377198 |
| quadratic analyses | 0.359001 |
|
CLICK HERE |
| 7998 |
Centers for Disease Control and Prevention |
Html |
en |
South Africa - Partners - Winnie Mandela Male Sexual Health Clinic |
null |
| young boys | 0.270456 |
| systematic process | 0.268917 |
| Mandela Male Sexual | 0.862083 |
| gender-based counseling | 0.292765 |
| site systems manager | 0.395381 |
| interactive educational video | 0.399306 |
| voluntary testing | 0.281452 |
| early stages | 0.253853 |
| clinic manager | 0.301815 |
| high quality | 0.258521 |
| community recruiters | 0.251492 |
| Ekurhuleni district | 0.286989 |
| educational preparation | 0.268989 |
| general assistants | 0.252433 |
| Health HIV/AIDS Strategic | 0.453395 |
| significant headway | 0.268059 |
| Winnie Mandela Clinic | 0.581024 |
| group information | 0.26269 |
| incorporation HIV | 0.283453 |
| Winnie Mandela Male | 0.929836 |
| clinic’s facilities | 0.304629 |
| Success Story | 0.257624 |
|
| Celebrates 10,000th Circumcision | 0.441528 |
| pilot phase | 0.271045 |
| previous Aurum projects | 0.43138 |
| data capturers | 0.254884 |
| data capturing systems | 0.407817 |
| easy tracking | 0.264933 |
| centralized records | 0.264272 |
| peer support | 0.263458 |
| Sexual Health Clinic | 0.778561 |
| community awareness | 0.252761 |
| non-federal site | 0.286193 |
| recovery rooms | 0.257073 |
| TB counseling | 0.296597 |
| fingerprint-based patient tracking | 0.422713 |
| Arum Institute | 0.289474 |
| South Africa province | 0.446087 |
| Male Sexual Health | 0.758312 |
| South Africa | 0.462775 |
| pre-operative medical assessments | 0.433822 |
| millennium development goals | 0.442809 |
| medical male circumcision | 0.757615 |
| efficient services | 0.254877 |
|
CLICK HERE |
| 8919 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Information Statement: Hepatitis A - Vaccines - CDC |
Hepatitis A Vaccine Information Statement |
| Compensation Program | 0.362554 |
| routine soreness | 0.371449 |
| hands properly. | 0.375042 |
| health care provider | 0.424876 |
| vision changes | 0.364842 |
| Page | 0.399876 |
| National Vaccine Injury | 0.549707 |
| liver failure | 0.373422 |
| nearest hospital | 0.362285 |
| severe allergic reaction | 0.770029 |
| hepatitis A research | 0.509861 |
| chronic liver disease | 0.426845 |
| dark urine | 0.377272 |
| known risks | 0.366425 |
| fast heartbeat | 0.363389 |
| liver disease | 0.446655 |
| severe allergy | 0.394166 |
| Vaccine Adverse Event | 0.540036 |
| hepatitis A-infected animals | 0.567545 |
| long-lasting protection | 0.374727 |
| VAERS website | 0.378576 |
| life-threatening allergic reaction | 0.45766 |
| low-grade fever | 0.374262 |
| hepatitis A. Hepatitis | 0.722429 |
|
| vaccine components | 0.508054 |
| vaccines | 0.38792 |
| United States | 0.37169 |
| severe stomach pains | 0.474611 |
| medical advice | 0.362232 |
| life-threatening allergies | 0.370653 |
| remote chance | 0.361213 |
| illegal drugs | 0.369197 |
| mild illness | 0.365643 |
| liver diseases | 0.3759 |
| vaccine package insert | 0.546411 |
| Current Edition Date | 0.443803 |
| Minor problems | 0.363681 |
| vaccine safety site | 0.545926 |
| joint pain | 0.371991 |
| people | 0.385286 |
| certain vaccines | 0.374939 |
| medical procedure | 0.362148 |
| hepatitis A virus | 0.533513 |
| hepatitis a vaccine | 0.980438 |
| federal program | 0.363709 |
| healthcare provider | 0.429395 |
| clay-colored bowel movements | 0.441191 |
| HAV). | 0.404565 |
|
CLICK HERE |
| 9229 |
Centers for Disease Control and Prevention |
Html |
en |
Notice to Readers: Final 2012 Reports of NationallyNotifiable Infectious Diseases |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| encephalitis virus disease | 0.904331 |
| equine encephalitis virus | 0.977619 |
| cases | 0.25264 |
| western equine encephalitis | 0.649114 |
| yellow fever | 0.445202 |
| United States | 0.437253 |
| smallpox | 0.208747 |
| syndrome-associated coronavirus disease | 0.633902 |
| anthrax | 0.209246 |
| virus infection | 0.400839 |
|
| eastern equine encephalitis | 0.651101 |
| chronic hepatitis | 0.424738 |
| Powassan virus | 0.436678 |
| poliomyelitis | 0.216254 |
| viral hemorrhagic fevers | 0.70881 |
| respiratory syndrome-associated coronavirus | 0.700036 |
| data quality review | 0.640176 |
| nonneuroinvasive disease | 0.344177 |
| hepatitis C virus | 0.403339 |
|
CLICK HERE |
| 11115 |
Centers for Disease Control and Prevention |
Html |
en |
B Virus | Signs and Symptoms | Herpes B | CDC |
Monkeys infected with B virus usually have no or only mild symptoms. In humans, however, B virus infection can result in acute ascending encephalomyelitis, resulting in death or severe neurologic impairment. |
| neurologic signs | 0.661765 |
| vesicular lesions | 0.648863 |
| symptom onset | 0.623507 |
| voluntary control | 0.576676 |
| latent infection | 0.683629 |
| number | 0.460041 |
| Respiratory failure | 0.579399 |
| extreme weakness | 0.583387 |
| antibodies | 0.465933 |
| asymptomatic B virus | 0.772473 |
| exposure site | 0.649305 |
| long-term neurologic problems | 0.798377 |
| flaccid paralysis | 0.619483 |
| diagnostic testing | 0.575469 |
| Respiratory involvement | 0.60497 |
| severe neurologic impairment | 0.891834 |
| actual incubation period | 0.769746 |
| lymph nodes | 0.622307 |
| supportive care | 0.572951 |
| reduced muscle tone | 0.75488 |
| human herpesviruses HSV-1 | 0.743717 |
| CNS involvement | 0.628453 |
| false-negative results | 0.574316 |
| muscle ache | 0.623177 |
|
| potential exposures | 0.576011 |
| high level | 0.575068 |
| death | 0.498873 |
| CNS complications | 0.622896 |
| fever | 0.472325 |
| mild symptoms | 0.651605 |
| muscle movements | 0.600472 |
| Neurologic symptoms | 0.707461 |
| infectious virus particles | 0.922455 |
| abdominal pain | 0.582017 |
| spinal cord | 0.606595 |
| antiviral therapy | 0.587201 |
| lymph vessels | 0.609312 |
| flu-like symptoms | 0.623262 |
| common cause | 0.567913 |
| Disease progression | 0.594445 |
| Disease onset | 0.626585 |
| virus infection | 0.836066 |
| acute ascending encephalomyelitis | 0.868686 |
| Initial symptoms | 0.609486 |
| headache | 0.481771 |
| vesicular skin lesions | 0.822705 |
| animal care workers | 0.714207 |
| humans | 0.519651 |
|
CLICK HERE |
| 12108 |
Centers for Disease Control and Prevention |
Html |
en |
Lung Cancer Rates by State |
Lung cancer statistics from CDC: incidence and mortality by state in the United States. |
| U.S. standard population | 0.640663 |
| Mortality Web-based Report | 0.658933 |
| United States | 0.743681 |
| USCS publication criteria | 0.414738 |
| Human Services | 0.403489 |
| States Cancer Statistics | 0.563005 |
| Statistics Working Group | 0.627154 |
| incidence data | 0.341954 |
| Incidence Rates* | 0.323692 |
|
| Cancer Statistics Working | 0.590522 |
| lung cancer | 0.930019 |
| United States Cancer | 0.563214 |
| lung cancer rates | 0.551538 |
| Disease Control | 0.402798 |
| National Cancer Institute | 0.608327 |
| lung cancer incidence | 0.590302 |
| U.S. Cancer Statistics | 0.571619 |
| Bronchus Cancer | 0.378345 |
|
CLICK HERE |
| 12752 |
Centers for Disease Control and Prevention |
Html |
en |
FastStats - Deaths and Mortality |
null |
| tables | 0.733579 |
| PDF | 0.728789 |
| Table | 0.715272 |
| United States | 0.963504 |
|
| MB | 0.830774 |
| Health | 0.718811 |
| Final Data | 0.972475 |
| Deaths | 0.852337 |
|
CLICK HERE |
| 13411 |
Centers for Disease Control and Prevention |
Html |
null |
Vaccines: VPD-VAC/Pertussis/main page |
Pertussis vaccine info for parents, public, and healthcare professionals |
|
|
CLICK HERE |